Effects of glucose-dependent insulinotropic polypeptide on glucagon

Research output: Contribution to journalReviewResearchpeer-review

Standard

Effects of glucose-dependent insulinotropic polypeptide on glucagon. / Christensen, Mikkel; Knop, Filip K.

In: Cardiovascular Endocrinology, Vol. 5, No. 3, 09.2016, p. 75-81.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Christensen, M & Knop, FK 2016, 'Effects of glucose-dependent insulinotropic polypeptide on glucagon', Cardiovascular Endocrinology, vol. 5, no. 3, pp. 75-81. https://doi.org/10.1097/XCE.0000000000000093

APA

Christensen, M., & Knop, F. K. (2016). Effects of glucose-dependent insulinotropic polypeptide on glucagon. Cardiovascular Endocrinology, 5(3), 75-81. https://doi.org/10.1097/XCE.0000000000000093

Vancouver

Christensen M, Knop FK. Effects of glucose-dependent insulinotropic polypeptide on glucagon. Cardiovascular Endocrinology. 2016 Sep;5(3):75-81. https://doi.org/10.1097/XCE.0000000000000093

Author

Christensen, Mikkel ; Knop, Filip K. / Effects of glucose-dependent insulinotropic polypeptide on glucagon. In: Cardiovascular Endocrinology. 2016 ; Vol. 5, No. 3. pp. 75-81.

Bibtex

@article{fa0d475af9d1403484aed2a22f37d59c,
title = "Effects of glucose-dependent insulinotropic polypeptide on glucagon",
keywords = "gastric inhibitory peptide, glucagon, glucose-dependent insulinotropic peptide, glucose-stabilizing intestinal peptide, incretin, incretin effect",
author = "Mikkel Christensen and Knop, {Filip K.}",
year = "2016",
month = sep,
doi = "10.1097/XCE.0000000000000093",
language = "English",
volume = "5",
pages = "75--81",
journal = "Cardiovascular Endocrinology",
issn = "2162-6898",
publisher = "Lippincott Williams & Wilkins",
number = "3",

}

RIS

TY - JOUR

T1 - Effects of glucose-dependent insulinotropic polypeptide on glucagon

AU - Christensen, Mikkel

AU - Knop, Filip K.

PY - 2016/9

Y1 - 2016/9

KW - gastric inhibitory peptide

KW - glucagon

KW - glucose-dependent insulinotropic peptide

KW - glucose-stabilizing intestinal peptide

KW - incretin

KW - incretin effect

U2 - 10.1097/XCE.0000000000000093

DO - 10.1097/XCE.0000000000000093

M3 - Review

VL - 5

SP - 75

EP - 81

JO - Cardiovascular Endocrinology

JF - Cardiovascular Endocrinology

SN - 2162-6898

IS - 3

ER -

ID: 177558552